Home › Funds › Capital Markets Trading UK LLP › TEVA

Capital Markets Trading UK LLP position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

Capital Markets Trading UK LLP reported holding 278,800 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q3 2026 13F filing — a position valued at US$11.0M, representing 0.76% of its reported portfolio and ranking #9 among its reported holdings. Capital Markets Trading UK LLP has disclosed TEVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)278.80K sh
Reported value held$11.04M
Portfolio Weight0.76%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Capital Markets Trading UK LLP's TEVA position evolved

Capital Markets Trading UK LLP first disclosed a stake in TEVA in Q3 2023 at 134,615 shares (US$1.4M). The position peaked in Q2 2026 at 433,800 shares, worth US$14.7M. Across 13 filings, Capital Markets Trading UK LLP increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 278,800 shares valued at US$11.0M — a reduction of -155,000 shares quarter over quarter.. Notable position changes include a 275% increase in Q2 2024 (shares rose 11% over the following quarter), a 403% increase in Q2 2025 (shares rose 21% over the following quarter), a 176% increase in Q1 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 134.62K $1.37M New
Q4 2023 100.85K $1.05M Reduce
Q1 2024 119.25K $1.68M Add
Q2 2024 447.41K $7.27M Add
Q3 2024 366.67K $6.61M Reduce
Q4 2024 503.97K $11.11M Add
Q1 2025 46.97K $722.00K Reduce
Q2 2025 236.22K $3.96M Add
Q3 2025 99.90K $2.02M Reduce
Q4 2025 59.60K $1.86M Reduce
Q1 2026 164.29K $4.95M Add
Q2 2026 433.80K $14.70M Add
Q3 2026 278.80K $11.04M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 48 other funds we track also report a position in TEVA — the largest reported positions include BANK OF MONTREAL /CAN/ (US$4.53B), Phoenix Financial Ltd. (US$1.69B), WCM INVESTMENT MANAGEMENT, LLC (US$1.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has Capital Markets Trading UK LLP held TEVA?

Capital Markets Trading UK LLP has disclosed TEVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Capital Markets Trading UK LLP's current position in TEVA?

As of Q3 2026, Capital Markets Trading UK LLP holds 278.80K shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $11.04M, representing 0.76% of its reported portfolio and ranking #9.

Has Capital Markets Trading UK LLP been buying or selling TEVA?

In the latest 13F filing (Q3 2026), Capital Markets Trading UK LLP reduced its position in TEVA. The position peaked in Q2 2026 at 433.80K shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include BANK OF MONTREAL /CAN/, Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.